Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) EBT: 2019-2024

Historic EBT for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to -$21.7 million.

  • Mainz Biomed N.V's EBT rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.66% up from last year.
  • According to the latest figures from FY2024, Mainz Biomed N.V's EBT is -$21.7 million, which was up 17.66% from -$26.3 million recorded in FY2023.
  • Mainz Biomed N.V's EBT's 5-year high stood at -$586,895 during FY2020, with a 5-year trough of -$26.4 million in FY2022.
  • In the last 3 years, Mainz Biomed N.V's EBT had a median value of -$26.3 million in 2023 and averaged -$24.8 million.
  • As far as peak fluctuations go, Mainz Biomed N.V's EBT spiked by 38.68% in 2020, and later tumbled by 1,891.86% in 2021.
  • Yearly analysis of 5 years shows Mainz Biomed N.V's EBT stood at -$586,895 in 2020, then slumped by 1,891.86% to -$11.7 million in 2021, then plummeted by 125.72% to -$26.4 million in 2022, then climbed by 0.35% to -$26.3 million in 2023, then grew by 17.66% to -$21.7 million in 2024.